Nitric oxide in septic shock

Biochimica et Biophysica Acta - Bioenergetics

Volumn 1411, Issue 2-3, 1999, Pages 437-455

  Titheradge, Michael A ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

Cardiovascular; Endotoxin; Liver; Nitric oxide; Septic shock

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ENZYME ACTIVITY; ENZYME INDUCTION; HUMAN; HYPOTENSION; LIVER DYSFUNCTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEPTIC SHOCK; SIGNAL TRANSDUCTION; TISSUE INJURY; VASCULAR SMOOTH MUSCLE;

ANIMALS; APOPTOSIS; ENDOTHELIUM, VASCULAR; ENZYME INDUCTION; HUMANS; LIPOPOLYSACCHARIDES; LIVER; MODELS, CHEMICAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; SHOCK, SEPTIC; SIGNAL TRANSDUCTION;

EID: 0032928083     PISSN: 00052728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2728(99)00031-6     Document Type: Review

References (109)

1. Bone R.C. Gram-positive organisms and sepsis. Arch. Intern. Med. 154:1994;26-34.
2. Rackow E.C., Astiz M.E. Pathophysiology and treatment of septic shock. J. Am. Med. Assoc. 266:1991;548-554.
3. G.M. Millar, C. Thiemermann, NO in septic shock, in: M.S. Goligorski, S. Gross (Eds.), Nitric Oxide and the Kidney. Physiology and Pathophysiology, Chapman and Hall, New York, 1997, pp. 271-306.
4. Thiemermann C. Nitric oxide and septic shock. Gen. Pharmacol. 29:1997;159-166.
5. Kilbourn R. Nitric oxide and shock. Dis. Mon. 43:1997;281-348.
6. Ceppi E.D., Smith F.S., Titheradge M.A. Nitric oxide, sepsis and liver metabolism. Biochem. Soc. Trans. 25:1997;929-934.
7. De Kimpe S.J., Kengatharan M., Thiemermann C., Vane J.R. The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc. Natl. Acad. Sci. USA. 92:1995;10359-10363.
8. De Kimpe S.J., Hunter M.L., Bryant C.E., Thiemermann C., Vane J.R. Delayed circulatory failure due to induction of nitric oxide synthase by lipoteichoic acid from Staphylococcus aureus in anaesthetised rats. Br. J. Pharmacol. 114:1995;1317-1323.
9. Waage A., Halstensen A., Shalaby R., Brandtzaeg P., Kierulf P., Espevik T. Local production of tumor necrosis factor-alpha, interleukin-1, and interleukin-6 in meningococcal meningitis - Relation to the inflammatory response. J. Exp. Med. 170:1989;1859-1867.
10. Heumann D., Barras C., Severin A., Glauser M.P., Tomasz A. Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infect. Immun. 62:1994;2715-2721.
11. Rees D.D., Cellek S., Palmer R.M.J., Moncada S. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock. Biochem. Biophys. Res. Commun. 173:1990;541-547.
12. Natanson C., Eichenholz P.W., Danner R.L., Eichacker P.Q., Hoffman W.D., Kuo G.C., Banks S.M., Macvittie T.J., Parrillo J.E. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J. Exp. Med. 169:1989;823-832.
13. Novogrodsky A., Vanichkin A., Patya M., Gazit A., Osherov N., Levitzki A. Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. Science. 264:1994;1319-1322.
14. Knowles R.G., Moncada S. Nitric oxide synthases in mammals. Biochem. J. 298:1994;249-258.
15. Morris S.M., Billiar T.R. New insights into the regulation of inducible nitric oxide synthesis. Am. J. Physiol. 266:1994;E829-E839.
16. Nathan C. Nitric-oxide as a secretory product of mammalian cells. FASEB J. 6:1992;3051-3064.
17. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:1991;109-142.
18. Knowles R.G., Moncada S. Nitric oxide as a signal in blood vessels. Trends Biochem. Sci. 17:1992;399-402.
19. 2+-independent nitric oxide synthases. FEBS Lett. 291:1991;145-149.
20. Gomez-Jimenez J., Salgado A., Mourelle M., Martin M.C., Segura R.M., Peracaula R., Moncada S. Nitric oxide pathway in endotoxemia and human septic shock. Crit. Care Med. 23:1995;253-257.
21. Kengatharan M., De Kimpe S.J., Thiemermann C. Analysis of the signal transduction in the induction of nitric oxide synthase by lipoteichoic acid in macrophages. Br. J. Pharmacol. 117:1996;1163-1170.
22. Bucher M., Ittner K.P., Zimmermann M., Wolf K., Hobbhahn J., Kurtz A. Nitric oxide synthase isoform III gene expression in rat liver is up-regulated by lipopolysaccharide and lipoteichoic acid. FEBS Lett. 412:1997;511-514.
23. Curran R.D., Billiar T.R., Stuehr D.J., Ochoa J.B., Harbrecht B.G., Flint S.G., Simmons R.L. Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis. Ann. Surg. 212:1990;462-469.
24. Ceppi E.D., Smith F.S., Titheradge M.A. Effect of multiple cytokines plus bacterial endotoxin on glucose and nitric oxide production by cultured hepatocytes. Biochem. J. 317:1996;503-507.
25. Szabo C., Wu C., Gross S., Thiemermann C., Perretti M., Vane J. Interleukin-1 contributes to the induction of nitric oxide synthase by endotoxin in vivo. Eur. J. Pharmacol. 250:1993;157-160.
26. Szabo C., Southan G.J., Thiemermann C. Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc. Natl. Acad. Sci. USA. 91:1994;12472-12476.
27. Nava E., Palmer R.M.J., Moncada S. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? Lancet. 338:1991;1555-1557.
28. Hinder F., Booke M., Traber L., Matsumoto N., Nishida K., Roger S., Traber D.L. Nitric oxide synthase inhibition during experimental sepsis improves renal excretory function in the presence of chronically elevated atrial natriuretic peptide. Crit. Care Med. 24:1996;131-136.
29. Macmicking J.D., Nathan C., Hom G., Chartrain N., Fletcher D.S., Trumbauer M., Stevens K., Xie Q.W., Sokol K., Hutchinson N., Chen H., Mudgett J.S. Altered responses to bacterial-infection and endotoxic-shock in mice lacking inducible nitric-oxide synthase. Cell. 81:1995;641-650.
30. Knowles R.G., Salter M., Brooks S.L., Moncada S. Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat. Biochem. Biophys. Res. Commun. 172:1990;1042-1048.
31. Szabo C., Thiemermann C., Wu C.C., Perretti M., Vane J.R. Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids. Proc. Natl. Acad. Sci. USA. 91:1994;271-275.
32. Salkowski C.A., Detore C., McNally R., van Rooijen N., Vogel S.N. Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo - The roles of macrophages, endogenous IFN-gamma, and TNF receptor-1-mediated signaling. J. Immunol. 158:1997;905-912.
33. Lee J.C., Young P.R. Role of Csbp/P38/Rk stress-response kinase in Lps and cytokine signaling mechanisms. J. Leukocyte Biol. 59:1996;152-157.
34. Yang R.-Y., Mark M.R., Gray A., Huang A., Xie M.H., Zhang M., Goddard A., Wood W.I., Gurney A.L., Godowski P.J. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature. 395:1998;284-288.
35. 2-terminal kinase mitogen-activated protein-kinases by bacterial peptidoglycan. J. Infect. Dis. 174:1996;777-785.
36. Saklatvala J., Davis W., Guesdon F. Interleukin 1 (IL1) and tumour necrosis factor (TNF) signal transduction. Phil. Trans. R. Soc. London B. 351:1996;151-157.
37. Ruetten H., Thiemermann C. Effects of tyrphostins and genistein on the circulatory failure and organ dysfunction caused by endotoxin in the rat: a possible role for protein tyrosine kinase. Br. J. Pharmacol. 122:1997;59-70.
38. Ruetten H., Thiemermann C. Effect of calpain inhibitor I, an inhibitor of the proteolysis of I kappa B, on the circulatory failure and multiple organ dysfunction caused by endotoxin in the rat. Br. J. Pharmacol. 121:1997;695-704.
39. A. Papapetropoulos, W.C. Sessa, Regulation of the NOS gene family, in: M.S. Goligorski, S.S. Gross (Eds.), Nitric Oxide and the Kidney. Physiology and Pathophysiology, Chapman and Hall, New York, 1997, pp. 66-85.
40. Perrella M.A., Patterson C., Tan L., Yet S.F., Hsieh C.M., Yoshizumi M., Lee M.E. Suppression of interleukin-1-beta-induced nitric-oxide synthase promoter/enhancer activity by transforming growth-factor-beta-1 in vascular smooth-muscle cells - Evidence for mechanisms other than NF-Kappa-B. J. Biol. Chem. 271:1996;13776-13780.
41. Kyriakis J.M., Avruch J. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J. Biol. Chem. 271:1996;24313-24316.
42. Woodgett J.R., Kyriakis J.M., Avruch J., Zon L.I., Zanke B., Templeton D.J. Reconstitution of novel signalling cascades responding to cellular stresses. Phil. Trans. R. Soc. London B. 351:1996;135-142.
43. Kyriakis J.M., Avruch J. Protein kinase cascades activated by stress and inflammatory cytokines. Bioessays. 18:1996;567-577.
44. Cohen P. The search for physiological substrates of MAP and SAP kinases in mammalian cells. Trends Cell Biol. 7:1997;353-361.
45. Uciechowski P., Saklatvala J., Vonderohe J., Resch K., Szamel M., Kracht M. Interleukin-1 activates Jun N-terminal kinases Jnk1 and Jnk2 but not extracellular regulated MAP kinase (Erk) in human glomerular mesangial cells. FEBS Lett. 394:1996;273-278.
46. Beyaert R., Cuenda A., Vanden Berghe W., Plaisance S., Lee J.C., Haegman G., Cohen P., Fiers W. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumour necrosis factor. EMBO J. 15:1996;1914-1923.
47. Lawler S., Cuenda A., Goedert M., Cohen P. SKK4, a novel activator of stress-activated protein kinase-1 (SAPK1/JNK). FEBS Lett. 414:1997;153-158.
48. Cuenda A., Cohen P., BueeScherrer V., Goedert M. Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38). EMBO J. 16:1997;295-305.
49. Paul A., Wilson S., Belham C.M., Robinson C.J.M., Scott P.H., Gould G.W., Plevin R. Stress-activated protein kinases: activation, regulation and function. Cell. Signal. 9:1997;403-410.
50. Kolesnick R., Golde D.W. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell. 77:1994;325-328.
51. Fernandez-Checa J.C., Kaplowitz N., Garcia-Ruiz C., Colell A., Miranda M., Mari M., Ardite E., Morales A. GSH transport in mitochondria: defense against TNF-induced oxidative stress and alcohol-induced defect. Am. J. Physiol. 273:1997;G7-G17.
52. Gómez-Muñoz A. Modulation of cell signalling by ceramides. Biochim. Biophys. Acta. 1391:1998;92-109.
53. Johns D.G., Osborn H., Webb R.C. A novel cell signaling mechanism for vasodilation. Biochem. Biophys. Res. Commun. 237:1997;95-97.
54. Baeuerle P.A. Pro-inflammatory signalling: last pieces in the NF-κB puzzle? Curr. Biol. 8:1998;R19-R22.
55. Ling L., Cao Z., Goeddel D.V. NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176. Proc. Natl. Acad. Sci. USA. 95:1998;3792-3797.
56. Nakano H., Shindo M., Sakon S., Nishinaka S., Mihara M., Yagita H., Okumura K. Differential regulation of IκB kinase α and β by two upstream kinases, NF-κK-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1. Proc. Natl. Acad. Sci. USA. 95:1998;3537-3542.
57. Wesselborg S., Bauer M.K.A., Vogt M., Schmitz M.L., Schulze Osthoff K. Activation of transcription factor NF-kappa B and p38 mitogen-activated protein kinase is mediated by distinct and separate stress effector pathways. J. Biol. Chem. 272:1997;12422-12429.
58. Duval D.L., Miller D.R., Collier J., Billings R.E. Characterization of hepatic nitric oxide synthase: identification as the cytokine-inducible form primarily regulated by oxidants. Mol. Pharmacol. 50:1996;277-284.
59. Carpentier I., Declercq W., Malinin N.L., Wallach D., Fiers W., Beyaert R. TRAF2 plays a dual role in NF-κB-dependent gene activation by mediating the TNF-induced activation of p38 MAPK and IκB kinase pathways. FEBS Lett. 425:1998;195-198.
60. Vanden Berghe W., Plaisance S., Boone E., De Bosscher K., Schmitz M.L., Fiers W., Haegeman G. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-κB p65 transactivation mediated by tumour necrosis factor. J. Biol. Chem. 273:1998;3285-3290.
61. Guan Z.H., Baier L.D., Morrison A.R. p38 mitogen-activated protein kinase down-regulates nitric oxide and up-regulates prostaglandin E(2) biosynthesis stimulated by interleukin-1 beta. J. Biol. Chem. 272:1997;8083-8089.
62. Kleinert H., Euchenhofer C., Ihrigbiedert I., Forstermann U. Glucocorticoids inhibit the induction of nitric-oxide synthase-II by down-regulating cytokine-induced activity of transcription factor nuclear factor-Kappa-B. Mol. Pharmacol. 49:1996;15-21.
63. Smith F.S., Ceppi E.D., Titheradge M.A. Inhibition of cytokine-induced inducible nitric oxide synthase expression by glucagon and cAMP in cultured hepatocytes. Biochem. J. 326:1997;187-192.
64. Oddis C.V., Simmons R.L., Hattler B.G., Finkel M.S. Protein kinase A activation is required for IL-1-induced nitric-oxide production by cardiac myocytes. Am. J. Physiol. 40:1996;C429-C434.
65. Harbrecht B.G., Wirant E.M., Kim Y.-M., Billiar T.R. Glucagon inhibits hepatocyte nitric oxide synthesis. Arch. Surg. 131:1996;1266-1272.
66. Kasai S., Kakisaka A., Kudo K., Mito M. Protective effects of dibutyryl cyclic AMP on acute hepatic failure in rats. J. Surg. Res. 66:1996;75-80.
67. Szabo C., Hasko G., Zingarelli B., Nemeth Z.H., Salzman A.L., Kvetan V., Pastores S.M., Vizi E.S. Isoproterenol regulates tumour necrosis factor, interleukin-10, interleukin-6 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxaemia. Immunology. 90:1997;95-100.
68. Rao G.N., Runge M.S. Cyclic AMP inhibition of thrombin-induced growth in vascular smooth muscle cells correlates with decreased JNK1 activity and c-Jun expression. J. Biol. Chem. 271:1996;20805-20810.
69. Harkema J.M., Dean R.E., Stephan R.N., Chaudry I.H. Cellular dysfunction in sepsis. J. Crit. Care. 5:1990;62-69.
70. Astiz M., Rackow E.C., Weil M.H., Schumer W. Early impairment of oxidative metabolism and energy production in severe sepsis. Circ. Shock. 26:1988;311-320.
71. L. Mela-Riker, H. Tavakoli, Effect of endotoxin on mitochondrial function, in: L.J. Berry (Ed.), Handbook of Endotoxin. Cellular Biology of Endotoxin, vol. 3, 1985, pp. 166-184.
72. Brown G.C., McBride A.G., Fox E.J., McNaught K.S., Borutaite V. Nitric oxide and oxygen metabolism. Biochem. Soc. Trans. 25:1997;901-904.
73. Poderoso J.J., Carreras M.C., Lisdero C., Riobo N., Schopfer F., Boveris A. Nitric-oxide inhibits electron-transfer and increases superoxide radical production in rat-heart mitochondria and submitochondrial particles. Arch. Biochem. Biophys. 328:1996;85-92.
74. Castro L., Rodriguez M., Radi R. Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide. J. Biol. Chem. 269:1994;29409-29415.
75. MacMillan-Crow L.A., Crow J.P., Kerby J.D., Beckman J.S., Thompson J.A. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal-allografts. Proc. Natl. Acad. Sci. USA. 93:1996;11853-11858.
76. Szabo C., Day B.J., Salzman A.L. Evaluation of the relative contribution of nitric-oxide and peroxynitrite to the suppression of mitochondrial respiration in immunostimulated macrophages using a manganese mesoporphyrin superoxide-dismutase mimetic and peroxynitrite. FEBS Lett. 381:1996;82-86.
77. J.S. Beckman, The physiological and pathological chemistry of nitric oxide, in: Nitric Oxide: Principles and Actions, Academic Press, New York, 1996, pp. 1-82.
78. Szabo C. Role of poly(ADP-ribose) synthetase activation in the suppression of cellular energetics in response to nitric oxide and peroxynitrite. Biochem. Soc. Trans. 25:1997;919-924.
79. Dimmeler S., Lottspeich F., Brüne B. Nitric oxide causes ADP-ribosylation and inhibition of glyceraldehyde-3-phosphate dehydrogenase. J. Biol. Chem. 267:1992;16771-16774.
80. Molina y Vedia L., McDonald B., Reep B., Brüne B., Di Silvio M., Billiar T.R., Lapetina E.G. Nitric oxide-induced S-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase inhibits enzymatic activity and increases endogenous ADP-ribosylation. J. Biol. Chem. 267:1992;24929-24932.
81. Packer M.A., Scarlett J.L., Martin S.W., Murphy M.P. Induction of mitochondrial permeability transition by peroxynitrite. Biochem. Soc. Trans. 25:1997;909-914.
82. 2+. Biochem. Soc. Trans. 25:1997;914-918.
83. Stadler J., Billiar T.R., Curran R.D., Stuehr D.J., Ochoa J.B., Simmons R.L. Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am. J. Physiol. Cell Physiol. 260:1991;C910-C916.
84. Stadler J., Curran R.D., Ochoa J.B., Harbrecht B.G., Hoffman R.A., Simmons R.L., Billiar T.R. Effect of endogenous nitric oxide on mitochondrial respiration of rat hepatocytes in vitro and in vivo. Arch. Surg. 126:1991;186-191.
85. Stadler J., Bentz B.G., Harbrecht B.G., Disilvio M., Curran R.D., Billiar T.R., Hoffman R.A., Simmons R.L. Tumor-necrosis-factor-alpha inhibits hepatocyte mitochondrial respiration. Ann. Surg. 216:1992;539-546.
86. Li T., Croce K., Winquist R. Regional differences in the effects of septic shock on the vessel reactivity in the rabbit. J. Pharmacol. Exp. Ther. 261:1992;959-963.
87. Boughton-Smith N.K., Evans S.M., Laszlo F., Whittle B.J.R., Moncada S. The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. Br. J. Pharmacol. 110:1993;1189-1195.
88. Whittle B.J.R. Nitric oxide in physiology and pathology. Histochem. J. 27:1995;727-737.
89. 2+-independent nitric oxide synthase in the myocardium. Br. J. Pharmacol. 105:1992;575-580.
90. Brady A.J.B., Poole W.P.A., Harding S.E., Warren J.B. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am. J. Physiol. 263:1992;H1963-H1966.
91. Klabunde R., Coston A. Nitric oxide synthase inhibition does not prevent cardiac depression in endotoxic shock. Shock. 3:1995;73-78.
92. Knowles R.G., Merrett M., Salter M., Moncada S. Differential induction of brain, lung and liver nitric oxide synthase by endotoxin in the rat. Biochem. J. 270:1990;833-836.
93. M. Di Silvio, A.K. Nussler, D.A. Geller, T.R. Billiar, A role for nitric oxide in liver inflammation and infection, in: Nitric Oxide: Principles and Actions, Academic Press, New York, 1996, pp. 219-236.
94. Ou J.H., Carlos T.M., Watkins S.C., Saavedra J.E., Keefer L.K., Kim Y.-M., Harbrecht B.G., Billiar T.R. Differential effects of non-selective nitric oxide synthase (NOS) and selective inducible NOS inhibition on hepatic necrosis, apoptosis, ICAM-1 expression and neutrophil accumulation during endotoxemia. Nitric Oxide Biol. Chem. 1:1997;404-416.
95. Kowalski-Saunders P.W.J., Winwood P.J., Arthur M.J.P., Wright R. Reversible inhibition of albumin production by rat hepatocytes maintained on a laminin-rich gel (Engelbreth-Holm-Swarm) in response to secretory products of Kupffer cells and cytokines. Hepatology. 16:1992;733-741.
96. Wilmore D.W., Aulick L.H., Powamda M.C., Mason H.D., Pruitt B.A. Effect of injury and infection on visceral metabolism and circulation. Ann. Surg. 192:1980;491-504.
97. Titheradge M.A., Knowles R.G., Smith F.S., Horton R.A., Ceppi E.D. Mechanism of inhibition of hepatic gluconeogenesis by bacterial endotoxin - a role for nitric-oxide. Biochem. Soc. Trans. 23:1995;1002-1008.
98. Horton R.A., Ceppi E.D., Knowles R.G., Titheradge M.A. Inhibition of hepatic gluconeogenesis by nitric oxide: a comparison with endotoxic shock. Biochem. J. 299:1994;735-739.
99. Casado M., Diaz-Guerra M.J.M., Bosca L., Martin-Sanz P. Characterization of nitric oxide dependent changes in carbohydrate hepatic metabolism during septic shock. Life Sci. 57:1996;561-572.
100. Stadler J., Barton D., Beilmoeller H., Diekmann S., Hierholzer C., Erhard W., Heidecke C.D. Hepatocyte nitric oxide biosynthesis inhibits glucose output and competes with urea synthesis for L-arginine. Am. J. Physiol. 268:1995;G183-G188.
101. Ou J., Molina L., Kim Y.-M., Billiar T.M. Excessive NO production does not account for the inhibition of hepatic gluconeogenesis in endotoxaemia. Am. J. Physiol. 271:1996;G621-G628.
102. Ceppi E.D., Titheradge M.A. Effect of multiple cytokines plus bacterial endotoxin on glucose and nitric oxide production by cultured hepatocytes. Arch. Biochem. Biophys. 349:1998;167-174.
103. Tepperman B.L., Brown J.F., Whittle B. Nitric-oxide synthase induction and intestinal epithelial-cell viability in rats. Am. J. Physiol. 265:1993;G214-G218.
104. Kuo P.C., Schroeder R.A. The emerging multifaceted role of nitric oxide. Ann. Surg. 221:1995;220-235.
105. Unno N., Wang H., Menconi M.J., Tytgat S.H.A.J., Larkin V., Smith M., Morin M.J., Chavez A., Hodin R.A., Fink M.P. Inhibition of inducible nitric oxide synthase ameliorates endotoxin-induced gut mucosal barrier dysfunction in rats. Gastroenterology. 113:1997;1246-1257.
106. Boughton-Smith N.K., Hutcheson I.R., Deakin A.M., Whittle B.J.R., Moncada S. Protective effect of S-nitroso-N-acetrylpenicillamine in endotoxin induced acute intestinal damage in the rat. Eur. J. Pharmacol. 91:1990;485-488.
107. Bohlinger I., Leist M., Gantner F., Angermuller S., Tiegs G., Wendel A. DNA fragmentation in mouse organs during endotoxic shock. Am. J. Pathol. 149:1996;1381-1393.
108. Fehsel K., Kroncke K.D., Meyer K.L., Huber H., Wahn V., Kolbachofen V. Nitric oxide induces apoptosis in mouse thymocytes. J. Immunol. 155:1995;2858-2865.
109. Dimmeler S., Zeiher A.M. Nitric oxide and apoptosis: another paradigm for the double-edged role of nitric oxide. Nitric Oxide Biol. Chem. 1:1997;275-281.